Patents by Inventor Don Bratton

Don Bratton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ESTROGEN MODULATORS
    Publication number: 20090131397
    Abstract: The present application is directed to a new class of isoxazoles and their use as estrogen modulators.
    Type: Application
    Filed: October 31, 2008
    Publication date: May 21, 2009
    Inventors: Simon Bailey, Stephen Douglas Barrett, Larry Don Bratton, Stephen Alan Fakhoury, Sandra Marie Jennings, Lorna Helen Mitchell, Raj Kumar Raheja, Veerabahu Shanmugasundaram
  • Chemokine receptor antagonists
    Publication number: 20020072606
    Abstract: The instant invention is a series of compounds which are MCP-1 receptor antagonists of Formula I 1
    Type: Application
    Filed: July 5, 2001
    Publication date: June 13, 2002
    Applicant: Warner-Lambert Company
    Inventors: Larry Don Bratton, Steven Robert Miller, Bruce David Roth, Bharat Kalidas Trivedi, Paul Charles Unangst
  • Chemokine receptor antagonists
    Patent number: 6316449
    Abstract: The instant invention is a series of compounds which are MCP-1 receptor antagonists of Formula I Also included in the invention are intermediates and processes for the preparation of the compounds as well as methods of using the compounds as agents for the treatment of atherosclerosis, chronic and acute inflammatory disease, chronic and acute immune disorders and transplant rejection as well as for preventing infection by HIV, treating infection by HIV, delaying the onset of AIDS, or treating AIDS.
    Type: Grant
    Filed: April 25, 2000
    Date of Patent: November 13, 2001
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Larry Don Bratton, Steven Robert Miller, Bruce David Roth, Bharat Kalidas Trivedi, Paul Charles Unangst
  • Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
    Patent number: 5922737
    Abstract: The present invention relates to novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl )benzamide derivatives of the formula: ##STR1## stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: July 13, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: George Daniel Maynard, John Michael Kane, Braulio Santiago, Elizabeth Mary Kudlacz, Larry Don Bratton, Christopher Robin Dalton
  • Display panel with a large realistic digitized high fidelity visual pattern and method for producing the same
    Patent number: 5395414
    Abstract: A novel display panel (10) has a high fidelity visual pattern with a full range of grey scale values, for instance, a marble or leather pattern, which is produced via a novel methodology (20). In accordance with the novel methodology (20), a high resolution visual pattern (31) and a mask pattern (32) are produced and separately printed. The patterns (31, 32) are then superimposed and exposed to a camera (33) which generates an enlarged photograph positive. A silk screen is produced from the enlarged photograph positive and used to print a high fidelity visual pattern onto a glass substrate (13). The glass substrate (13) and visual pattern (14) are then heated in a tempering oven to derive the display panel (10).
    Type: Grant
    Filed: April 14, 1993
    Date of Patent: March 7, 1995
    Assignee: Dover Designs, Inc.
    Inventors: Donald J. Matasick, Don Bratton